AzTrials
AzTrials

Medication AdherenceNCT06230978

Evaluation of a Habit-based Work-up to Support Medication Adherence

A study testing Habit workup and Standard Medication Counseling in people with Medication Adherence and Habits, run by University of Iowa at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to test the impact of a medication-taking habit worksheet and discussion with a pharmacist in patients who are prescribed a new chronic medication for cardiovascular disease or depression. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Medication Adherence, Habits
What is being tested?
Habit workup and Standard Medication Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteUnited States
Study dates
1 Apr 2024to 28 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must be fluent to speak and write in English,
  • must be prescribed a new chronic medication

Who cannot join

  • Does not manage their own medications independently

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cedar Valley Primary Care & Walk-In Clinic | Waterloo IA

    Waterloo, Iowa, 50701

Other trials in United States

About this study

Official title: Evaluation of a Habit-based Work-up to Support Medication Adherence in Primary Care

The goal of this clinical trial is to test the impact of a medication-taking habit worksheet and discussion with a pharmacist in patients who are prescribed a new chronic medication for cardiovascular disease or depression. The main questions it aims to answer are:

  • What is the feasibility and acceptability of the workup from the perspective of the patients and the clinic?
  • What is the impact of the intervention on the formation of medication-taking habits compared to a comparison group who receive standard pharmacist counseling?
  • What is the difference in medication adherence beliefs and behaviors for the group receiving the habit workup compared to those receiving standard counseling?
Read the detailed description

The purpose of this study is to evaluate a habit adherence workup delivered by pharmacy in primary care. The study population will include patients taking new medications for chronic conditions like high blood pressure, high cholesterol, diabetes, and depression.

This study uses a sequential design which involves first evaluating 16 patients without the added habit worksheet, and then the second phase evaluates 16 patients with the habit worksheet. All participants meet with the pharmacist and are provided standard counseling on the new medications. All participants complete the pre and post survey.

The pharmacist will be trained on the medication habit workup worksheet which has the patient choose cues they will use to develop their medication-taking habit. These will include associating the new habit with hygiene habits like toothbrushing, other habits like making coffee or eating breakfast, or visual cues like setting medications out where they will be easily noticed when doing other habits like getting dressed. Patients will take their sheet with them as a reminder of their plan. Patients also will receive medication counseling. The encounters will occur in a private clinic room.

All participants will complete baseline and follow-up surveys, which will include space for open-ended comments.

Being tested
Habit workup, Standard Medication Counseling
Keywords
Medication adherence, Habit, Medication Beliefs, Pharmacist
Medical subject headings
Medication Adherence, Habits

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Habit workupBehavioural

    The patient and pharmacist will work together to specify a cue to help them take their medicine every day (e.g. brushing teeth, getting dressed, eating breakfast, making coffee, alarms, visual reminders etc).

  • Standard Medication CounselingBehavioural

    The pharmacist provides standard counseling on the new medication

Study groups in NCT06230978
Study groupRoleWhat they receive
Standard of careActive comparatorThe first 16 patients will receive standard medication counseling from the pharmacist
Receives: Behavioral: Standard Medication Counseling
Habit workup armExperimentalThe second 16 patients will receive the habit workup in addition to medication counseling
Receives: Behavioral: Habit workup; Behavioral: Standard Medication Counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Medication Adherence Report Scale

    Five-items from the medication Adherence Report scale assessed using 5-point Likert scale. Possible range 5-25 (higher values associated with greater medication adherence)

    Measured: From enrollment to 100 days following

  2. 4-item Habit Automaticity Index

    This 4 scale uses four validated items from the Habit Automaticity Index and uses a 5-point Likert scale. Possible range 4-20 (higher values associated with greater automaticity of medication-taking habit)

    Measured: From enrollment to 100 days following

Secondary outcomes (1)
  1. Beliefs about Medicines Questionnaire

    For this study,, 5 items specific, 5 items general from the beliefs about Medicines questionnaire by Horne. Possible range 5-25 for each scale. (for the specific beliefs, lower values are associated with more positive medication beliefs, with the general, higher numbers are associated with greater medication beliefs)

    Measured: From enrollment to 100 days following

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start1 Apr 2024
  3. Primary completion28 Feb 2025
  4. Study completion28 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06230978
Sponsor's protocol ID
202311617
Status last verified
May 2024
First submitted
19 Jan 2024
Last updated
5 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data on primary and secondary outcomes, and basic demographic information

Publications

  • Witry M, Hoehns J, Phillips LA. Pilot of a pharmacist-delivered habit-based intervention to support medication adherence in primary care. Res Social Adm Pharm. 2026 Jan;22(1):147-151. doi: 10.1016/j.sapharm.2025.09.003. Epub 2025 Sep 6.

    PubMed 40946014

Questions about this trial

What is this clinical trial studying?

A study testing Habit workup and Standard Medication Counseling in people with Medication Adherence and Habits, run by University of Iowa at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Medication Adherence Report Scale (time frame: From enrollment to 100 days following). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06230978, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in